Hi @Patient
Thanks for taking the time to add some thoughts.
The directors who actually bought stock post IPO did so between 18-22 November for averages of 67.5c - 72.1c. Maybe one of them paid <60c for some shares - but I doubt it. Given the complete lack of buying since, their purchases look a lot like token efforts to demonstrate support post IPO.
In my view you are dead right about Tony, and also about TIS burning a lot of investors who might otherwise be interested in TRP. And, that the cash is never going to hit holders' back pockets; it's going to be spent so that holders end up with either a zero or a hero, something of which no-one can complain - it's not as though that has been kept a secret! And, I agree fully that sentiment about biotechs is currently poor.
But none of that impacts on my primary point: TRP can do vastly better when it comes to self-promotion. Its failure to do so falls at the feet of the directors.
FD
- Forums
- ASX - By Stock
- TRP
- Ann: Appendix 4D and Half Year Report to 31 December 2021
Ann: Appendix 4D and Half Year Report to 31 December 2021, page-4
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TRP (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.0¢ |
Change
-0.025(7.25%) |
Mkt cap ! $20.86M |
Open | High | Low | Value | Volume |
34.0¢ | 34.0¢ | 32.0¢ | $73.56K | 223.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 18000 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.0¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6600 | 0.335 |
3 | 164651 | 0.330 |
1 | 15873 | 0.320 |
2 | 8225 | 0.310 |
1 | 3000 | 0.305 |
Price($) | Vol. | No. |
---|---|---|
0.345 | 2556 | 1 |
0.350 | 19078 | 1 |
0.370 | 5000 | 1 |
0.380 | 4000 | 1 |
0.395 | 10000 | 1 |
Last trade - 10.27am 07/10/2024 (20 minute delay) ? |
Featured News
TRP (ASX) Chart |